NCT06837480View on ClinicalTrials.gov

Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 30, 2029

Study Completion Date

November 30, 2029

Conditions
Head and Neck CancerLymphedema of the Head and Neck
Interventions
DEVICE

LTU-904 Portable Laser Therapy Unit (active laser device)

The RianCorp LTU-904 laser therapy unit (active laser device) will be used for photobiomodulation therapy (PBMT).

DEVICE

LTU-904 Portable Laser Therapy Unit (sham/inactive laser device)

The RianCorp LTU-904 laser therapy (sham/inactive laser device) unit will be used for sham therapy.

Trial Locations (2)

19104

University of Pennsylvania Abramson Cancer Center, Philadelphia

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER